IGF-1 LONG R3 – $69.95
IGF-1 LONG R3 (IGF1 LR3) is a research peptide that is not recommended or intended for human use.
There are many different types of “research peptides” including IGF-1 LONG R3 that are being offered.
Research peptides like IGF-1 LONG R3 are to be used for research purposes only and are not approved to be taken by humans.
IGF-1 is a polypeptide hormone and exhibits some of the same molecular properties as insulin. IGF stands for insulin-like growth factor.
IGF-1 Long R3
Insulin-like growth factor is a natural product of physiological processes in the body. It is a peptide hormone synthesized as a result of workings of Pituitary gland and Growth Hormone. Puberty is the age at which the Insulin-like growth factor is most active in a human body. During that period high levels of the Insulin-like Growth Factor help, among other things, accelerate the skeletal muscles growth.
IGF-1 Long R3 and IGF-1 are isoforms, i.e. they are different types of the same protein and have similar effects on the molecular and cellular processes in the body. IGF-1 LR3 is an enhanced version of Insulin-like Growth factor. It has 83 amino acids and is considerably more potent. One of the differences between the two and the great advantage of the IGF-1 Long R3 is the fact that it has a longer period of activity and a half-life of more than 20 hours, which means its effects last about three times longer than those of Insulin-like Growth Factor 1. The same thing makes the basic Insulin-like Growth Factor not so effective, especially compared to IGF-1 Long R3. IGF-1 Long R3 enables a greater nutrients and amino acids uptake in muscle cells. It forces the amino acids into the cells and therefore ensures the protein synthesis to be an easier and a faster process. Other effects include fat loss and better vascularity.
Another highly favorable effect of IGF-1 Long R3 is hyperplasia (muscles growth). Opposed to the muscle mass increase caused by the growth of the already existing cells (sometimes referred to as hypertrophy), hyperplasia is a process of creating entirely new muscle cells. The cells go through mitosis, split and form new muscle cells. The new cells can be brought to full maturity through weight training. Without the IGF-1 Long R3 only size growth of the already existing muscle cells is possible, whereas the IGF-1 Long R3 gives the possibility of enhancing muscle density through the actual increase of the number of muscle cells in a skeletal muscle tissue.
A group of medical professionals conducted a research of IGF-1 LR3. They tested and compared the effects of IGF-1 LR3 to the effects of mere training. The results showed the IGF-1 LR3 to be more efficient. Moreover, benefits of IGF-1 LR3 proved to be longer lasting. Some of the results indicated that using the IGF-1 LR3 during life can lead to preserving and decreasing the loss of fast muscle fibers and keeping their speed and force values at satisfactory levels even at an elderly age. Having taken into account all of the previous information obtained during the study, the researchers concluded that there are some strong indicators of possible anti-aging effects of IGF-1 Long R3.
Although it is not possible to completely explain the processes behind it, many might be interested in the facts showing that IGF-1 LR3 prevents the shrinkage of testicles, works against atrophy of testicles and even reverses it. The same effects were achieved in cases where IGF-1 LR3 was applied in the middle of a steroid cycle.
——————–
IGF-1 is manufactured recombinantly on a large scale. Many evaluations have been made of IGF-1 in clinical trials for a variety of indications, including growth failure, type 1 diabetes, type 2 diabetes, amyotrophic lateral sclerosis (ALS aka “Lou Gehrig’s Disease”), severe burn injury and myotonic muscular dystrophy (MMD). Results of clinical trials evaluating the efficacy of IGF-1 in type 1 diabetes and type 2 diabetes showed great promise in reducing hemoglobin A1C levels, as well as daily insulin consumption. Cephalon and Chiron conducted two pivotal clinical studies of IGF-1 for ALS, and although one study demonstrated efficacy, the second was equivocal, and the product has never been approved by the FDA.
http://en.wikipedia.org/wiki/Insulin-like_growth_factor_1
IGF-1 is primarily responsible for long bone growth in children and it also affects muscle growth and repair of adults. Long R3 IGF-1 (a.k.a. IGF-1 LONG R3) is a much stronger version of IGF-1. IGF-1 LONG R3 is chemically altered to prevent deactivation by IGF-1 binding proteins in the bloodstream. This results in a much longer half-life of 20-30 hours instead of 20 min like the regular IGF-1 has.
IGF-1 greatly boosts muscle mass by inducing a state of muscle hyperplasia (increase in number of new muscle cells) in the body, but because of its short half-life (20 minutes), it is somewhat ineffective and difficult to take. IGF-1 LONG R3 is more effective because of its significantly longer half-life.
Long R3 IGF-1 / IGF-1 LONG R3 can directly stimulate muscle growth when compared to growth hormone (HGH). This is because GH indirectly results in growth and repair by first inducing IGF-1 release in the liver. If you don’t have to worry about IGF-1 release in the liver (because your directly injecting the IGF-1), new growth will be optimized.
Is IGF-1 of greater or lesser value when it comes to healing injured tissue?
Tissue build up is one of the main features of IGF-1. Long R3 IGF-1 / IGF-1 LONG R3 is of greater value. IGF-1 can genetically change muscular and cellular counts within the body; it can also enhance the body’s ability to regenerate damaged tissue. In fact, IGF-1 is now under intensive research for its potential to repair tissue in burn patients, and for its regenerative effects on AIDS patients suffering from muscular wasting. Immediate effects are, of course, impossible to observe since it takes a respectable amount of time to see any visible changes in muscular repair.
Again, Long R3 IGF-1 / IGF-1 LONG R3 is for research purposes only and is not to be used for bodybuilding, fat loss or other non-research related purposes.
